HLA typing reads the inherited versions of the genes that display protein fragments. The name tells you how precisely the version is known, not whether a tumour still shows a given fragment.
In an allele name such as HLA-A*02:01:01:01 the fields carry distinct meanings (official HLA nomenclature). HLA-A is the gene; 02 is the allele group, which often corresponds to a serological antigen; the second field (01) distinguishes protein sequences within the group, since alleles differing there differ in at least one amino-acid-changing substitution; the third field distinguishes synonymous coding differences; the fourth distinguishes differences outside the coding region. An optional suffix gives expression status: N for a null allele, and L, S, C, A or Q for alternatively expressed alleles, L meaning significantly reduced surface expression. A name without a suffix is not a measurement of how much HLA a cancer cell expresses. A shared first field does not establish identical proteins, and a report stating only A*02 at group resolution cannot be silently completed as A*02:01.
People generally inherit one copy of each HLA gene from each parent, so a report lists two alleles per locus, which can be the same name. Class I and class II typing describe different display molecules. Typing identifies inheritance; it does not show tumour retention or expression, peptide display or receptor recognition, and a negative display assay does not by itself show the typing was wrong. Loss of an allele in the tumour, or changes in antigen-processing machinery, can interrupt the chain after an accurate typing result. A trial may name an allele and an accepted method; eligibility belongs to the study team and neither a similar name nor correct typing shows targetability.
Laboratory typing starts from an accepted specimen and extracted DNA, tests sequence patterns with primers or probes or reads selected regions by Sanger or next-generation sequencing, optionally after PCR amplification, and compares the result with a reference database (IPD-IMGT/HLA). Hosomichi et al. (2013) describe phase-defined sequencing of six HLA genes by long-range PCR and multiplex sequencing: phasing connects differences on the same inherited copy, and unresolved phase or a missing distinguishing region can leave alternative allele pairs despite good base quality. More reads of the same regions cannot settle such an ambiguity; the distinguishing information must be added, and both alternatives should be kept until it is. Software can infer class I HLA from genome, exome or RNA sequencing: Szolek et al. (2014) reported OptiType's overall accuracy of 97 per cent on their benchmark of RNA, exome and whole-genome data. Capture, coverage and expression affect such inference, and an inference is not automatically a laboratory result accepted for clinical use. Reports should be read with resolution, ambiguity notes, coverage, database version and validation.
The IPD-IMGT/HLA statistics page read on 9 November 2026 listed 46,146 HLA alleles, 31,311 of them class I and 14,835 class II, so exact allele names matter.
In plain words · HLA-A is the molecule that holds up short pieces of a cell's proteins for T cells to inspect. Engineered T-cell receptor therapies such as tebentafusp and afami-cel only work in people with the HLA-A*02 variant, because the receptor recognises the tumour peptide sitting in that particular groove.
Showing the target this term concerns: HLA-A.
Shares Neoantigen candidate selection, HLA (human leukocyte antigen) and MHC.
Shares Antigen-processing machinery (APM), HLA (human leukocyte antigen) and MHC.
Shares Antigen-processing machinery (APM), HLA (human leukocyte antigen) and MHC.
Shares Antigen-processing machinery (APM), HLA (human leukocyte antigen) and MHC.
Shares Antigen-processing machinery (APM), HLA (human leukocyte antigen) and MHC.
Shares Tumour-associated antigen (TAA), Antigen-processing machinery (APM), HLA (human leukocyte antigen) and MHC.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/